mk 0663 has been researched along with Arthritis, Rheumatoid in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 33 (82.50) | 29.6817 |
| 2010's | 7 (17.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, X; Mei, H; Tian, M; Zhang, W | 1 |
| Bilthariya, U; Jain, AK; Jain, N; Rajoriya, V | 1 |
| Gammaitoni, A; Greenwald, M; Kvien, TK; Mehta, A; Peloso, PM; Wang, H | 1 |
| Bickham, K; Frontera, N; Kivitz, AJ; Mehta, A; Peloso, PM; Popmihajlov, Z; Shah, S; Stryszak, P | 1 |
| Davies, NM; Remsberg, CM; Reynolds, JK; Takemoto, JK; Vega-Villa, KR | 1 |
| Cannon, CP; Connors, LG; Curtis, SP; Goldkind, L; Laine, L; Yanqiong, Z | 1 |
| Brater, DC; Cannon, CP; Curtis, SP; Kaur, A; Krum, H; Laine, L; Smugar, SS; Swergold, G; Wang, H; Weir, MR | 1 |
| Croom, KF; Siddiqui, MA | 1 |
| Agrawal, NG; Bachmann, K; Cavanaugh, PF; Gottesdiener, K; Hoelscher, D; Marbury, T; Miller, J; Schwartz, JI; Wong, PH | 1 |
| Berens, N; Bröcker, EB; Seitz, CS; Trautmann, A | 1 |
| Alekseeva, LI | 1 |
| Brune, K; Cannon, CP; Contant, CF; Curtis, SP; Jarolim, P; Kaur, A; Laine, L; Morrow, DA; Ren, F; Ruff, CT | 1 |
| Day, R | 1 |
| Borenstein, D; Curtis, S; Gertz, BJ; Lines, CR; Mandel, DR; Matsumoto, AK; McIlwain, HH; Melian, A; Zhao, PL | 1 |
| Bowen, B; Callegari, P; Evans, J; Harper, S; Hunt, RH; James, C; Quan, H; Rashid, F; Yu, C | 1 |
| Capone, ML; Patrignani, P; Tacconelli, S | 1 |
| Hunsche, E; Mavros, P; Querol, J; Ramos-Remus, CR; Suarez, R | 1 |
| Crespi, S; Hunsche, E; Moore, A; Pellissier, J; Phillips, C | 1 |
| Leclercq, P; Malaise, MG | 1 |
| Bolognese, JA; Curtis, S; Krupa, D; Watson, DJ; Yu, C | 1 |
| Eichler, HG; Geling, O; Hunsche, E; Kong, S; Mavros, P | 1 |
| Hochberg, MC | 1 |
| Carracedo-Martínez, E | 1 |
| Krüger, K | 2 |
| Bolognese, JA; Cannon, CP; Curtis, SP; Laine, L | 1 |
| Bolognese, JA; Bombardier, C; Cannon, CP; Curtis, SP; Erdmann, E; FitzGerald, GA; Kaur, A; Krum, H; Laine, L; Reicin, AS; van der Heijde, D; Weinblatt, ME | 1 |
| Leung, TW; Wong, EH; Wong, KS | 1 |
| Bolognese, JA; Cavanaugh, PF; Curtis, SP; Ko, AT; Reicin, AS | 1 |
| Cannon, CP; Cryer, B; Curtis, SP; Kaur, A; Laine, L | 1 |
| Einecke, D | 2 |
| Baraf, HS | 1 |
| Curtis, SP; Matsumoto, A; Melian, A; Shah, A | 1 |
| Curtis, S; Dore, R; Kaur, A; Krueger, K; Lino, L; Radominski, S; Simpson, R; Zhang, Y | 1 |
| Klotz, U; Shi, S | 1 |
| Mielke, F; Schweigert, M | 1 |
| Derry, S; McQuay, HJ; Moore, RA | 1 |
| Casas, N; Collantes, E; Curtis, SP; Gertz, BJ; Lee, KW; Lee, M; Lines, CR; McCarthy, T; McCormick, CL; Melian, A; Rodgers, DB; Zhao, PL | 1 |
15 review(s) available for mk 0663 and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Naproxen; Osteoarthritis; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2018 |
Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib.
Topics: Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etoricoxib; Humans; Liver Failure; Osteoarthritis; Pain; Pyridines; Renal Insufficiency; Sulfones | 2008 |
Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis.
Topics: Arthritis, Gouty; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Osteoarthritis; Pyridines; Spondylitis, Ankylosing; Sulfones | 2009 |
Leg ulceration in rheumatoid arthritis--an underreported multicausal complication with considerable morbidity: analysis of thirty-six patients and review of the literature.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Rheumatoid; Etoricoxib; Female; Gram-Positive Bacterial Infections; Humans; Isoxazoles; Leflunomide; Leg; Leg Ulcer; Male; Methotrexate; Middle Aged; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Pyridines; Retrospective Studies; Risk Factors; Sulfones | 2010 |
[Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) study pro
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Etoricoxib; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Osteoarthritis; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome | 2010 |
Another selective COX-2 inhibitor: more questions than answers?
Topics: Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Etoricoxib; Humans; Isoenzymes; Membrane Proteins; Naproxen; Prostaglandin-Endoperoxide Synthases; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2002 |
Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor.
Topics: Arthritis, Gouty; Arthritis, Rheumatoid; Cardiovascular System; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Etoricoxib; Humans; Isoenzymes; Low Back Pain; Membrane Proteins; Osteoarthritis; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones | 2003 |
[Etoricoxib (Arcoxia)].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Cyclooxygenase 2; Etoricoxib; Humans; Isoenzymes; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones | 2004 |
COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Humans; Isoxazoles; Lactones; Membrane Proteins; Organic Chemicals; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Rheumatology; Sulfonamides; Sulfones; Treatment Outcome | 2005 |
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Etoricoxib; Gout; Humans; Osteoarthritis; Placebos; Pyrazoles; Pyridines; Rheumatic Diseases; Spondylitis, Ankylosing; Sulfonamides; Sulfones | 2005 |
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Osteoarthritis; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Thrombosis | 2006 |
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Female; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Osteoarthritis; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyridines; Sulfones | 2007 |
Efficacy of the newest COX-2 selective inhibitors in rheumatic disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Hemorrhage; Humans; Membrane Proteins; Osteoarthritis; Patient Selection; Pyridines; Rheumatic Diseases; Risk Assessment; Risk Factors; Spondylitis, Ankylosing; Sulfones | 2007 |
Clinical use and pharmacological properties of selective COX-2 inhibitors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Monitoring; Etoricoxib; Humans; Osteoarthritis; Pain; Pyrazoles; Pyridines; Sulfonamides; Sulfones | 2008 |
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports.
Topics: Arthritis, Rheumatoid; Drug Administration Schedule; Etoricoxib; Humans; Musculoskeletal Diseases; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2008 |
11 trial(s) available for mk 0663 and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial
Topics: Analgesics; Arthralgia; Arthritis, Rheumatoid; Biological Products; Colombia; Cyclooxygenase 2 Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Etoricoxib; Health Status; Humans; North America; Pain Measurement; Pyridines; Sulfones; Surveys and Questionnaires; Switzerland; Time Factors; Treatment Outcome | 2015 |
Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines; Sulfones; Young Adult | 2016 |
How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Hospitalization; Humans; Liver Diseases; Male; Middle Aged; Osteoarthritis; Pyridines; Risk Factors; Sulfones | 2009 |
Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Pressure; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Osteoarthritis; Pyridines; Sulfones | 2009 |
Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Etoricoxib; Female; Humans; Male; Methotrexate; Middle Aged; Pyridines; Sulfones | 2009 |
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disability Evaluation; Double-Blind Method; Etoricoxib; Female; Health Status; Humans; Isoenzymes; Joints; Male; Membrane Proteins; Middle Aged; Naproxen; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Pyridines; Severity of Illness Index; Sulfones; Surveys and Questionnaires; Treatment Outcome | 2002 |
Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Duodenal Ulcer; Etoricoxib; Female; Gastrointestinal Hemorrhage; Humans; Ibuprofen; Isoenzymes; Male; Membrane Proteins; Middle Aged; Occult Blood; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyridines; Stomach Ulcer; Sulfones | 2003 |
Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks treatment with anti-inflammatory agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Etoricoxib; Health Status; Humans; Naproxen; Pyridines; Quality of Life; Sulfones; Surveys and Questionnaires | 2005 |
Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Placebos; Prospective Studies; Pyridines; Sulfones; Treatment Outcome | 2007 |
Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pyridines; Sulfones; Treatment Outcome | 2008 |
A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].
Topics: Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Etoricoxib; Female; Humans; Hypertension; Male; Middle Aged; Naproxen; Pain Measurement; Pyridines; Sulfones | 2002 |
14 other study(ies) available for mk 0663 and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib.
Topics: Animals; Arthritis, Rheumatoid; Cattle; Drug Delivery Systems; Etoricoxib; Folic Acid; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Pyridines; Serum Albumin, Bovine; Sulfones | 2015 |
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diclofenac; Etoricoxib; Female; Heart Failure; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Osteoarthritis; Peptide Fragments; Prospective Studies; Pyridines; Retrospective Studies; Risk Factors; Sulfones; Thrombosis; Treatment Outcome | 2011 |
Evaluation of quality of life following treatment with etoricoxib in patients with arthritis or low-back pain: an open label, uncontrolled pilot study in Mexico.
Topics: Administration, Oral; Adult; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Etoricoxib; Female; Humans; Low Back Pain; Male; Mexico; Middle Aged; Osteoarthritis; Pain Measurement; Patient Satisfaction; Pilot Projects; Pyridines; Quality of Life; Sulfones | 2004 |
Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etoricoxib; Gastrointestinal Diseases; Histamine H2 Antagonists; Humans; Middle Aged; Misoprostol; Models, Economic; Osteoarthritis; Proton Pump Inhibitors; Pyridines; Quality-Adjusted Life Years; Risk; Sulfones; Time Factors; United Kingdom | 2004 |
[Rapidly acting and powerful antirheumatic drug now also approved in Germany. Arcoxia (etoricoxib, MSD)]].
Topics: Acute Disease; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Approval; Etoricoxib; Gout; Humans; Indomethacin; Osteoarthritis; Pain Measurement; Pyridines; Sulfones | 2004 |
Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Double-Blind Method; Dyspepsia; Etoricoxib; Humans; Low Back Pain; Osteoarthritis; Patient Compliance; Protective Agents; Pyridines; Randomized Controlled Trials as Topic; Retrospective Studies; Spondylitis, Ankylosing; Sulfones | 2004 |
Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Etoricoxib; Humans; Osteoarthritis; Proton Pump Inhibitors; Pyridines; Sulfones; United Kingdom | 2005 |
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Osteoarthritis; Patient Selection; Pyridines; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Sulfones; Treatment Outcome | 2006 |
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Osteoarthritis; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2006 |
Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
Topics: Adult; Arthritis, Rheumatoid; Cerebral Infarction; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Etoricoxib; Humans; Immunosuppressive Agents; Intracranial Thrombosis; Male; Pyridines; Sulfones; Thalidomide | 2007 |
[By what means does the rheumatic patient with gastrointestinal risks fare best?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Controlled Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Gastrointestinal Diseases; Germany; Humans; Naproxen; Osteoarthritis; Proton Pump Inhibitors; Pyridines; Rheumatic Diseases; Risk Factors; Sulfones; United States | 2007 |
[Coronary risks with NSAID and coxibs. The end of hysteria].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Cause of Death; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Osteoarthritis; Peptic Ulcer; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Risk; Sulfones; Thrombosis | 2006 |
[3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Humans; Osteoarthritis; Peptic Ulcer; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Risk; Sulfones | 2006 |
Safe adalimumab therapy for rheumatoid arthritis in a patient with pre-existing multiple myeloma.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Etoricoxib; Humans; Lactones; Male; Methotrexate; Middle Aged; Multiple Myeloma; Pyridines; Retrospective Studies; Severity of Illness Index; Sulfones | 2008 |